In Partnership with:
3408 Stories, most recent news story added 35 minutes ago
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market.
( University of California - Irvine ) The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries -- a finding that could expand the clinical trial to include people with cervical damage.
IRVINE — Human embryonic stem cells could help people with learning and memory deficits after radiation treatment for brain tumors, suggests a new UC Irvine study.
( Johns Hopkins Medical Institutions ) The same genes that are chemically altered during normal cell differentiation, as well as when normal cells become cancer cells, are also changed in stem cells that scientists derive from adult cells, according to new research from Johns Hopkins and Harvard.
The same genes that are chemically altered during normal cell differentiation, as well as when normal cells become cancer cells, are also changed in stem cells that scientists derive from adult cells, according to new research from Johns Hopkins and Harvard.
WILMINGTON, Delaware, November 3 /PRNewswire/ -- The new market research report, 'Global Stem Cell and Advanced Technologies Market' (2009 - 2014)', published by MarketsandMarkets (http://www.marketsandmarkets.com) analyzes the major trends in the global stem cell market.
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme - preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
Breckenridge: 'Marty's great adventure' has happy ending By CAITLIN ROW summit daily news Breckenridge, Colorado BRECKENRIDGE - Marty Lessow, owner of Marty's for Kids in Breckenridge, is cancer free after a blood stem cell transplant performed in May. Lessow originally went to the hospital more than two years back with heart problems, and that's when doctors discovered his cancer infection. He ...
FRIDAY, Nov. 6 (HealthDay News) -- Belgian scientists who used embryonic stem cells to create lung tissue say this technique could provide an alternative to lung transplants for patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
British scientists begin a new study on Tuesday to consider how human DNA is used in animal experiments and to determine what the boundaries of such controversial science might be.
Salk Institute scientists found that dual-purpose switches controlled many of the genes activated in the regenerating cells of a zebra fish’s tail.
British scientists begin a new study on Tuesday to consider how human DNA is used in animal experiments and to determine what the boundaries of such controversial science might be.
British scientists begin a new study on Tuesday to consider how human DNA is used in animal experiments and to determine what the boundaries of such controversial science might be.
67 WALL STREET, New York - November 10, 2009 - The Wall Street Transcript has recently published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212 ...
LONDON - British scientists begin a new study on Tuesday to consider how human DNA is used in animal experiments and to determine what the boundaries of such controversial science might be.
Value-focused mutual fund firm Tweedy Browne singled out financials and technology stocks in a letter this month.
Open slideshowAFP/Getty Images/File
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
